Executive Team

  • Dr Shane Smith

    CEO & CO-FOUNDER

    Shane is an experienced innovator in medical technologies with a 10-year track record of business success and entrepreneurship. He worked in NovaBiotics Ltd commercialising biologics and in BioCyto Ltd as COO. Shane earned his Master’s in Medical Bio-Business and a PhD in Medical Sciences from University of Aberdeen.

  • Dr Eoin Scanlan

    CSO & CO-FOUNDER

    Eoin is an organic and medical chemistry who leads an international research team in Trinity College Dublin with a focus on biomolecular synthesis, including peptides, proteins and glycoconjugates toward the development of novel therapeutics, diagnostics and biomaterials. Eoin is a PhD graduate of the University of St. Andrews and completed postdoctoral work at the University of Oxford.

  • Dr Paula Colavita

    CTO & CO-FOUNDER

    Paula has unique experience in the design and development of advanced functional materials. She leads a research team in Trinity College Dublin whose activities focus on understanding and achieving control of interfacial processes and reactions. Paula completed her PhD at the University of South Carolina and carried out postdoctoral research work at the University of Wisconsin-Madison.

Board of Directors

  • Aisling Campbell

    CHAIRPERSON

    Aisling is an investment director for PanEuro Technology Ventures and has over 15 years of Financial and People Management experience. She has supported businesses from startups to large-scale companies and as Chair of Glycome BioPharma, she brings strategic leadership and expertise to the role.

  • Ultan Molloy

    NON-EXECUTIVE DIRECTOR

    A seasoned serial investor spanning over 20 early-stage companies and a background in pharmacy, Ultan brings his wealth of knowledge and experience to the board of Glycome Biopharma. Over the past decade, he has played a pivotal role in the Irish MedTech syndicate, leading diligence processes.